New highly specific agonistic peptides for human melanocortin MC1 receptor

Peptides

Volumn 21, Issue 2, 2000, Pages 239-243

  Szardenings, Michael ^a   Muceniece, Ruta ^a   Mutule, Ilze ^a   Mutulis, Felikss ^a   Wikberg, Jarl E S ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Melacure Therapeutics AB   (Sweden)

Author keywords

Melanocortin receptors; Melanocyte stimulating hormone; Receptor selective peptides

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; ALPHA INTERMEDIN[4 NORLEUCINE 7 DEXTRO PHENYLALANINE]; CYCLIC AMP; IODINE 125; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR; MS 04; MS 05; MS 06; MS 09; PEPTIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL CULTURE; CELL STRAIN COS1; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG SYNTHESIS; INFLAMMATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

ANTI-INFLAMMATORY AGENTS; BINDING, COMPETITIVE; CELL LINE; CYCLIC AMP; HUMANS; IODINE RADIOISOTOPES; PEPTIDES; PROTEIN BINDING; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN;

EID: 0034126009     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00207-7     Document Type: Article

References (25)

1. Adan R.A.H., Oosterom J., Ludvigsdottir G., Brakkee J.H., Burbach J.P.H., Gispen W.H. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors. Eur J Pharmacol. 269:1994;331-337.
2. Campbell M.J. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques. 18:1995;1027-1032.
3. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
4. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Comm. 195:1993;866-873.
5. Eberle AN. The melanotropins: chemistry, physiology and mechanisms of action. Basel: Karger, Switzerland, 1988.
6. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem. 268:1993;8246-8250.
7. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem. 268:1993;15174-15179.
8. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Comm. 200:1994;1214-1220.
9. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem. 38:1995;3454-3461.
10. Kask A., Mutulis F., Muceniece R., Pähkla R., Mutule I., Wikberg J.E.S., Rägo L., Schiöth H.B. Discovery of a novel superpotent and selective melanocortin 4 receptor antagonist (HS024) Evaluation in vitro and in vivo . Endocrinology. 139:1998;5006-5014.
11. Lerner A.B., Lee T.H. Isolation of a homogenous melanocyte-stimulating hormone from hog pituitary gland. J Am Chem Soc. 77:1955;1066-1067.
12. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
13. Nordstedt C., Fredholm B.B. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem. 189:1990;231-234.
14. Sahm U.G., Olivier G.W., Branch S.K., Moss S.H., Pouton C.W. Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides. 15:1994;1297-1302.
15. Sawyer T.K., Sanfilippo P.J., Hruby V.J., Engel M.H., Heward C.B., Burnett J.B., Hadley M.E. 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone a highly potent α-melanotropin with ultralong biological activity . Proc Natl Acad Sci USA. 77:1980;5754-5758.
16. Schiöth H.B., Muceniece R., Wikberg J.E.S., Chhajlani V. Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol. 288:1995;311-317.
17. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterization of the melanocortin 4 receptor by radioligand binding. Pharmacol Toxicol. 79:1996;161-165.
18. Schiöth H.B., Kuusinen A., Muceniece R., Szardenings M., Keinänen K., Wikberg J.E.S. Expression of functional melanocortin 1 receptors in insect cells. J Biophys Res Comm. 221:1996;807-814.
19. Schiöth H.B., Muceniece R., Prusis P., Szardenings M., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E.S. Characterisation of D117A and, H260A mutations in the melanocortin 1 receptor. Mol Cell Endocrinol. 126:1997;213-219.
20. Schiöth HB, Muceniece R, Larsson M, Mutulis F, Szardenings M, Prusis P, Lindeberg G, Wikberg JES. Binding of cyclic and linear MSH core peptides to melanocortin receptor subtypes, Eur J Pharmacol 1997;319:369-73.
21. Schiöth H.B., Mutulis F., Muceniece R., Prusis P., Wikberg J.E.S. Discovery of novel melanocortin 4 receptor selective MSH analogues. Br J Pharmacol. 124:1998;75-82.
22. Solca F.F., Chluba-de-Tapia J., Iwata K., Eberle A.N. B16-G4F mouse melanoma cells an MSH receptor-deficient cell clone . Febs Lett. 322:1993;177-180.
23. Szardenings M., Törnroth S., Muceniece R., Keinänen K., Kuusinen A., Wikberg J.E.S. Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J Biol Chem. 272:1997;27943-27948.
24. Tatro J.B. Receptor biology of the melanocortins, a family of neuroimmuno-modulatory peptides. Neuroimmunomodulation. 3:1996;259-284.
25. Wikberg J.E.S. Melanocortin receptors perspectives for novel drugs . Eur J Pharmacol. 375:1999;295-310.